Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration

Journal of Clinical Investigation

Volumn 122, Issue 9, 2012, Pages 3159-3169

  Fanara, Patrizia ^a   Wong, Po Yin A ^a   Husted, Kristofor H ^a   Liu, Shanshan ^a   Liu, Victoria M ^a   Kohlstaedt, Lori A ^b   Riiff, Timothy ^a   Protasio, Joan C ^a   Boban, Drina ^a   Killion, Salena ^a   Killian, Maudi ^c   Epling, Lorrie ^c   Sinclair, Elisabeth ^c   Peterson, Julia ^c   Price, Richard W ^c   Cabin, Deborah E ^d   Nussbaum, Robert L ^c   Brühmann, Jörg ^e   Brandt, Roland ^e   Christine, Chadwick W ^c   Aminoff, Michael J ^c   Hellerstein, Marc K ^b,f   more..

^a KINEMED INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF OSNABRÜCK   (Germany)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; CHROMOGRANIN B; DEUTERIUM; DEUTERIUM OXIDE; NERVE PROTEIN; NEU DIFFERENTIATION FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MICROTUBULE; MOUSE; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER TRANSPORT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SECRETION; PROTEIN TRANSPORT; TRANSPORT KINETICS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONAL TRANSPORT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMOGRANIN B; FEMALE; HUMANS; KINETICS; MALE; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MUTATION, MISSENSE; NEUREGULIN-1; NOCODAZOLE; NOSCAPINE; PACLITAXEL; PARKINSON DISEASE, SECONDARY; SUPEROXIDE DISMUTASE; TAU PROTEINS; TUBULIN MODULATORS;

EID: 84865956863     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64575     Document Type: Article

References (50)

1. Thoenen H, Sendtner M. Neurotrophins: From enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci. 2002;5(suppl):1046-1050. (Pubitemid 35247196)
2. Chevalier-Larsen E, Holzbaur EL. Axonal transport and neurodegenerative disease. Biochim Biophys Acta. 2006;1762(11-12):1094-108. (Pubitemid 44750577)
3. Roy S, Zhang BV, Lee M-Y, Trojanowski JQ. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol. 2005;109(1):5-13. (Pubitemid 40287785)
4. El-Kadi M, Soura V, Hafezparast M. Defective axonal transport in motor neuron disease. J Neurosci Res. 2007;85(12):2557-2566. (Pubitemid 47344558)
5. Gunawardena S, et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron. 2003;40(1):25-40. (Pubitemid 37222462)
6. Her LS, Goldstein LS. Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J Neurosci. 2008;28(50):13662- 12672.
7. Collard JF, Cote F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375(6526):61-64.
8. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALSlinked SOD1 mutants to motor neurons. Nat Neurosci. 1999;2(1):50-56. (Pubitemid 30488940)
9. Kabuta T, et al. Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly inter acts with tubulin. Biochem Biophy Res Commun. 2009;387(1):121-126.
10. Strey CW, et al. Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol. 2004;165(5):1701-1718. (Pubitemid 39435168)
11. Lee HJ, Khoshaghideh F, Lee S, Lee SJ. Impairment of microtubule- dependent trafficking by overexpression of alpha-synuclein. Eur J Neurosci. 2006;24(11):3153-3162. (Pubitemid 44952647)
12. Saha AR, et al. Parkinson's disease a-synuclein mutations exhibit defective axonal transport in culture neurons. J Cell Sci. 2004;117(7):1017- 1024. (Pubitemid 38456084)
13. Qureshi HY, Paudel HK. Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) and α-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem. 2011;286(7):5055-5068.
14. Fanara P, et al. In vivo measurement of microtubule dynamics using stable isotope labeling with heavy water. Effect of taxanes. J Biol Chem. 2004;279(48):49940-49947. (Pubitemid 39577802)
15. Fanara P, et al. Stabilization of hyperdynamic microtubule is neuroprotective in ALS. J Biol Chem. 2007;282(32):23465-23472. (Pubitemid 47311905)
16. Fanara P, et al. Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice. Neuroscience. 2010;168(1):167-178.
17. Barten DM, et al. Hyperdynamic microtubules, cognitive deficits and pathology are improved in tau transgenic mice with low doses of the microtubule stabilizing agent, BMS-241027. J Neurosci. 2012;32(21):7137-7145.
18. Guzik BW, Goldstein LS. Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. Curr Opin Cell Biol. 2004;16(4):443-450. (Pubitemid 38903151)
19. Cartelli D, Ronchi C, Maggioni MG, Rodighiero S, Gavini E, Cappelletti G. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ induced neurodegeneration. J Neurochem. 2010;115(1):247-258.
20. Goldstein LS, Yang Z. Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci. 2000;23:39-71. (Pubitemid 30350037)
21. Johanson CE, Stopa EG, McMillan PN. The bloodcerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol. 2011;686:101-13.
22. Thouvenot E, et al. Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J Proteome Res. 2008;7(10):5509-4421.
23. Kaether C, Skehel P, Dotti CG. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell. 2000;11(4):1213-1224. (Pubitemid 30211025)
24. Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615-29619.
25. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9(1):108-118. (Pubitemid 43011916)
26. Ricart K, et al. Interactions between β-neuregulin and neurotrophins in motor neuron apoptosis. J Neurochem. 2006;97(1):222-233.
27. Steinacker P, et al. Soluble beta-amyloid precursor protein is related to disease progression and amyotrophic lateral sclerosis. PLoS One. 2011;6(8):e23600.
28. Pankonin MS, Sohi J, Kamholz J, Loeb JA. Differential distribution of neuregulin in human brain and spinal fluid. Brain Res. 2009;1258:1-11.
29. Borghi R, et al. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett. 2000;287(1):65-67. (Pubitemid 30332379)
30. Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha synuclein and its aggregates. J Neurosci. 2005;25(25):6016-6024. (Pubitemid 40911433)
31. Hansen C, et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest. 2011;121(2):715-725.
32. Hisahara S, Shimohma S. Toxin-induced and genetic animal models of Parkinson's disease. Parkinsons Dis. 2010;2011:951709.
33. Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res. 2005;134(1):57-66. (Pubitemid 40409495)
34. Wang B, Yang L, Wang Z, Zheng H. Amyloid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proc Natl Acad Sci U S A. 2007;104(35):14140-14145. (Pubitemid 350003348)
35. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4(4):253-265. (Pubitemid 38525281)
36. Zho J, Panda D, Landen JW, Wilson L, Joshi HC. Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint. J Biol Chem. 2002;277(19):17200-17208. (Pubitemid 34967753)
37. Marx KA, Zhou T, Montrone A, McIntosh D, Braunhunt SJ. A comparative study of the cytoskeleton binding drugs nocodazole and taxol with the mammalian cell quartz crystal miroblalance biosensor: different dynamic response and energy dissipation effects. Anal Biochem. 2007;361(1):77-92. (Pubitemid 46026996)
38. Zhang B, et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc Natl Acad Sci U S A. 2005;102(1):227-231. (Pubitemid 40094457)
39. Gurney ME. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol. 1997;224(2):15-20.
40. Drewes G, et al. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamics instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem. 1995;270(13):7679-7688.
41. Cabin DE, Gispert-Sanchez S, Murphy D, Auburger G, Myers RR, Nussbaum RL. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background. Neurobiol Aging. 2005;26(1):25-35. (Pubitemid 39600588)
42. Hellerstein MK, et al. Subpopulations of long-lived and short lived T cells in advanced HIV-1 infection. J Clin Invest. 2003;112(6):956-966. (Pubitemid 38063753)
43. Li W, Hoffman PN, Stirling W, Price DL, Lee MK. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations. J Neurochem. 2004;88(2):401- 410.
44. Mollenbauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG. &alpha-Synuclein and tau concentrations in cerebrospinal fluid of patient presenting with parkinsonism: a cohort study. Lancet Neurol. 2011;10(3):230-240.
45. Tulu US, Rusan NM, Wadsworth P. Peripheral, non-centrosome-associated microtubules contribute to spindle formation in centrosome-containing cells. Curr Biol. 2003;13(21):1894-1899. (Pubitemid 37347933)
46. Fath T, Eidenmüller J, Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci. 2002;22(22):9733-9741. (Pubitemid 35332856)
47. Weissmann C, Reyher HJ, Gauthier A, Steinhoff HJ, Junge W, Brandt R. Microtubule binding and trapping at the tip of neurites regulate tau motion in living neurons. Traffic. 2009;10(11):1655-1668.
48. Gauthier-Kemper A, Weissmann C, Reyher HJ, Brandt R. Monitoring cytoskeletal dynamics in living neurons using fluorescence photoactivation. Methods Enzymol. 2012;505:3-21.
49. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-184.
50. Busch R, et al. Measurement of protein turnover rates by heavy water labeling of nonessential amino acids. Biochim Biophys Acta. 2006;1760(5):730-44.